Skip to main content

Breast Cancer

Original Research, Adverse Events, Breast Cancer, Infections

Evaluating Adverse Events in Patients with Breast Cancer and HIV Infection Receiving Concomitant Antiretroviral Therapy and Chemotherapy with Curative Intent

Donyika Joseph, PharmD, BCOP, Farnaz Foolad, PharmD, BCPS, Neelam K. Patel, PharmD, BCOP, Meghan Karuturi, MD, MSc, Jaime Kaushik, PharmD, BCOP

Donyika Joseph, PharmD, BCOP; Farnaz Foolad, PharmD, BCPS; Neelam K. Patel, PharmD, BCOP; Meghan Karuturi, MD, MSc; Jaime Kaushik, PharmD, BCOP

HOPA Highlights, Breast Cancer

Advances in Breast Cancer Treatments: Are We Extending Patients’ Survival?

Meg Barbor, MPH

Meg Barbor, MPH

HOPA Abstracts, Breast Cancer, CDK4/6 Inhibitors

Development and Implementation of a Pharmacist-Led Virtual Clinic Improve the Management of Patients with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors

Abstract #CR04

HOPA Abstracts, Breast Cancer

Time to Treatment Initiation and Outcomes for Patients with Nonmetastatic Breast Cancer Before and During the COVID-19 Pandemic at Community Cancer Centers

Abstract #LB04

Case Reports, Breast Cancer, Adverse Events

Spontaneous Tumor Lysis Syndrome in a Patient with Stage IV HER2-Positive Breast Cancer: Case Report

Blake T. Robbins, PharmD, MBA , Alexander M. Kreimer, PharmD, BCPS , Reema A. Patel, MD, Allison R. Butts, PharmD, BCOP

Blake T. Robbins, PharmD, MBA; Alexander M. Kreimer, PharmD, BCPS; Reema A. Patel, MD; Allison R. Butts, PharmD, BCOP

Clinical Trials, Breast Cancer

Sacituzumab Govitecan Moves to Second-Line Therapy for Metastatic Triple-Negative Breast Cancer: Applying the Lessons from Clinical Trials to Clinical Practice

Breast Cancer

A Subanalysis of the Phase 3 MONARCH 3 Study of Abemaciclib as Initial Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer

Effectiveness of Alpelisib plus Fulvestrant Compared with Real-World Standard Treatment Among Patients with HR-Positive, HER2-Negative, PIK3CA Mutation–Positive Breast Cancer

Breast Cancer

Updates on Endocrine Therapy for Metastatic Breast Cancer

Breast Cancer

Patient-Reported Outcomes from a Phase 3 Trial in Premenopausal Patients with ER-Positive, HER2-Negative, Lymph Node–Positive Breast Cancer

Page 3 of 12
Results 21 - 30 of 116